
Krishna Institute of Medical Sciences Approves Preferential Allotment of Warrants to Promoter Group
Krishna Institute of Medical Sciences Ltd. (KIMS) has announced the approval of a preferential allotment of warrants to members of its promoter and promoter group. The move, ratified by the Board of Directors on June 13, 2026, aims to raise capital through the issuance of these financial instruments.The Board approved the creation, offer, and issue of a total of 77,02,182 warrants. Each warrant is fully convertible into one equity share of the company, which has a face value of ₹ 2/-. The warrants were issued at a Warrant Issue Price of ₹ 779.00 per unit, with a premium of ₹ 777.00.
The preferential allotment was completed in a private placement basis and resulted in an aggregate consideration receivable of ₹ 599,99,99,778/- from the allottees. The warrants are set to be exercised over a period of 18 months from the date of allotment.
Details of Warrant Issuance
The issuance details show that three individuals and one limited liability partnership (LLP) received the allotted warrants, all falling under the Promoter and Promoter Group category.The breakdown of the proposed allotments and the corresponding financial commitment is as follows:
| Proposed Allottee Name | Category | Number of Warrants Proposed | Aggregate Consideration Receivable (₹) |
|---|---|---|---|
| Dr. Abhinay Bollineni | Promoter | 32,09,242 | ₹ 2,49,99,99,518/- |
| Mr. Adwik Bollineni | Promoter | 32,09,242 | ₹ 2,49,99,99,518/- |
| Bharas Ventures LLP | Promoter Group | 12,83,698 | ₹ 1,00,00,00,742/- |
| Total | 77,02,182 | ₹ 5,99,99,99,778/- |
Shareholding Impact and Future Plans
The transaction details provide insight into the resulting post allotment shareholding percentages for the promoter group. Prior to this issue, the Promoter and Promoter Group held a shareholding of 34.11%. Following the potential full conversion of all issued warrants, the Promoters are expected to hold approximately 35.35% of the company's equity.The Warrants are structured such that holders must pay an amount equivalent to 25% of the Warrant Issue Price upon subscription. The remaining 75% payment must be made at the time of exercising the right to convert the warrants into equity shares.
In addition to the warrant issuance, the Board meeting also approved the convening of an Extra-Ordinary General Meeting (EGM). This EGM is scheduled for July 9, 2026, and is intended to seek necessary approval from the company's members regarding these corporate matters.
KIMS Stock Price Movement
On Friday, shares of Krishna Institute of Medical Sciences Limited edged higher to settle at ₹785.1, recording a strong gain of 2.30%. The stock saw significant trading activity, with a total volume reaching 483,256 as it closed out the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.